Naturally occurring mutations of the luteinizing-hormone receptor: Lessons learned about reproductive physiology and G protein-coupled receptors

American Journal of Human Genetics

Volumn 65, Issue 4, 1999, Pages 949-958

  Latronico, Ana Claudia ^a   Segaloff, Deborah L ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUTEINIZING HORMONE RECEPTOR;

GENE MAPPING; GENE MUTATION; GENE STRUCTURE; HUMAN; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SEXUAL DEVELOPMENT; SIGNAL TRANSDUCTION;

EID: 0033361906     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302602     Document Type: Article

References (49)

1. Abell AN, McCormick D, Segaloff DL (1998) Certain activating mutations within helix 6 of the human luteinizing hormone receptor may be explained by alterations that allow transmembrane regions to activate Gs. Mol Endocrinol 12:1857-1869
2. Abell AN, Segaloff DL (1997) Evidence for the direct involvement of transmembrane region six of the lutropin/choriogonadotropin receptor in activating Gs. J Biol Chem 272:14586-14591
3. Arnhold IJP, Latronico AC, Batista MC, Carvalho FM, Chrousos GP, Mendonca BB (1997) Ovarian resistance to luteinizing hormone: a novel cause of amenorrhea and infertility. Fertil Steril 67:394-397
4. Arnhold IJP, Latronico AC, Batista MC, Mendonca BB (1999) Menstrual disorders and infertility caused by inactivating mutations of the luteinizing hormone receptor gene. Fertil Steril 71:1-5
5. Baranski TJ, Herzmark P, Lichtarge O, Gerber BO, Trueheart J, Meng EC, Iiri T, et al (1999) C5a receptor activation: genetic identification of critical residues in four transmembrane helices. J Biol Chem 274:15757-15765
6. Bertezene F, Forest MG, Grimaud JA, Claustrat B, Mornex R (1976) Leydig cell agenesis: a cause of male pseudohermaphroditism. N Engl J Med 295:969-972
7. Bond RA, Leff P, Johnson TD, Milano CA, Rockman HA, McMinn TR, Apparsundaram S, et al (1995) Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β2-adrenoreceptor. Nature 374:272-276
8. Ehrman DA, Barnes RB, Rosenfield RL (1995) Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322-353
9. Epstein FH (1997) The thyrotropin receptor in thyroid diseases. N Engl J Med 337:1675-1681
10. Evans BAJ, Bowen DJ, Smith PJ, Clayton PE, Gregory JW (1996) A new point mutation in the luteinising hormone receptor gene in familial and sporadic male limited precocious puberty: genotype does not always correlate with phenotype. J Med Genet 33:143-147
11. Gether U, Kobilka BK (1998) G protein-coupled receptors. II. Mechanism of agonist activation. J Biol Chem 273:17979-17982
12. Gromoll J, Partsch C-J, Simoni M, Nordhoff V, Sippell WG, Nieschlag E, Saxena BB (1998) A mutation in the first transmembrane domain of the lutropin receptor causes male precocious puberty. J Clin Endocrinol Metab 83:476-480
13. Gromoll J, Simoni M, Nieschlag E (1996) An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hyophysectomized man. J Clin Endocrinol Metab 81:1367-1370
14. Hjorth SA, Orskov C, Schwartz TW (1998) Constitutive activity of glucagon receptor mutants. Mol Endocrinol 12:78-86
15. Kawate N, Kletter GB, Wilson BE, Netzloff ML, Menon KMJ (1995) Identification of constitutively activating mutation of the luteinising hormone receptor in a family with male limited gonadotrophin independent precocious puberty (testotoxicosis). J Med Genet 32:553-554
16. Kjelsberg MA, Cotecchia S, Ostrowski J, Caron MC, Lefkowitz RJ (1992) Constitutive activation of the a1B-adrenergic receptor by all amino acid substitutions at a single site. J Biol Chem 267:1430-1433
17. Kosugi S, Lin Z, Pearlstein R, Mori T, Shenker A (1997) Evidence that interhelical hydrogen bonding between Asp 578 and Asp 619 helps maintain the inactive conformation of the human lutropin receptor (LHR). Endocrine Society, Minneapolis
18. Kosugi S, Mori T, Shenker A (1936) The role of Asp578 in maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor. J Biol Chem 271:31813-31817
19. _ (1998) An anionic residue at position 564 is important for maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor. Mol Pharmacol 53:895-901
20. Kosugi S, Van Dop C, Geffner ME, Rabl W, Carel JC, Chaussain JL, Mori T, et al (1995) Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. Hum Mol Genet 4:183-188
21. Kraaij R, Post M, Kremer H, Milgrom E, Epping W, Brunner HG, Grootegoed AJ, et al (1995) A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familiar male precocious puberty. J Clin Endocrinol Metab 80:3168-3172
22. Kremer H, Kraaij R, Toledo SPA, Post M, Fridman JB, Hayashida CY, van Reen M, et al (1995) Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet 9:160-164
23. Kremer H, Madman E, Otten BJ, Moll GW Jr, Stoelinja GB, Wit JM, Jansen M, et al (1993) Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Genet 2:1779-1783
24. Kudo M, Osuga Y, Kobilka BK, Hsueh AJW (1996) Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop. J Biol Chem 271:22470-22478
25. Latronico AC, Abell AN, Arnhold IJP, Liu X, Lins TSS, Brito VN, Billerbeck AE, et al (1998) A unique constitutively activating mutation in the third transmembrane helix of the luteinizing hormone receptor causes sporadic male gonadotropin independent precocious puberty. J Clin Endocrinol Metab 83:2435-2440
26. Latronico AC, Anasti J, Arnhold IJ, Mendonca BB, Domenice S, Albano MC, Zachman K, et al (1995) A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab 80:2490-2494
27. Latronico AC, Anasti J, Arnhold IJP, Rapaport R, Mendonca BB, Bloise W, Castro M, et al (1996) Testicular and ovarian resistance to luteinizing hormone caused by homozygous inactivating mutations of the luteinizing hormone receptor gene. N Engl J Med 334:507-512
28. Latronico AC, Chai Y, Arnhold IJ, Liu X, Mendonca BB, Segaloff DL (1998) A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol Endocrinol 12:442-450
29. Laue L, Chan W-C, Hsueh A, Kudo M, Hsu SY, Wu S, Blomberg L, et al (1995a) Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci USA 92:1906-1910
30. Laue LL, Wu SM, Kudo M, Bourony CJ, Cutler GB, Hsueh AJW, Chan WY (1996) Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol Endocrinol 10:987-997
31. Laue L, Wu SM, Kudo M, Hsueh AJW, Cutler GB Jr, Griffin JE, Wilson JD, et al (1995b). A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet 4:1429-1433
32. Martens JWM, Verhoef-Post M, Abelin N, Ezabella M, Toledo SPA, Brunner HG, Themmen APN (1998) A homozygous mutation of the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype. Mol Endocrinol 12:775-784
33. Misrabi M, Meduri G, Pissard S, Bouvattier C, Beau I, Loosfelt H, Jolivet A, et al (1997) Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. J Clin Endocrinol Metab 82:2159-2165
34. Risma KA, Hirshfield AN, Nilson JH (1997) Elevated luteinizing hormone in prepubertal transgenic mice causes hyperandrogenemia, precocious puberty, and substantial ovarian pathology. Endocrinology 138:3540-3547
35. Roberts LM, Shen J, Ingraham HA (1999) New solutions to an ancient riddle: defining the differences between Adam and Eve. Am J Hum Genet 65:933-942 (in this issue)
36. Rosenthal IM, Refetoff S, Rich B, Barnes RB, Sunthornthepvarakul T, Parma J, Rosenfield RL (1996) Response to challenge with gonadotropin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor-a clinical research center study. J Clin Endocrinol Metab 81:3802-3806
37. Rousseau-Merck MF, Misrahi M, Atger M, Loosfelt H, Milgrom E, Berger R (1990) Localization of the human luteinizing hormone/choriogonadotropin receptor gene (LHCGR) to chromosome 2p21. Cytogenet Cell Genet 54:77-79
38. Rozell TG, Wang H, Liu X, Segaloff DL (1995) Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not the lutropin/choriogonadotropin receptor. Mol Endocrinol 9:1727-1736
39. Saldanha PH, Arnhold IJP, Mendonca BB, Bloise W, Toledo SPA (1987) A clinic-genetic investigation of Leydig cell hypoplasia. Am J Med Genet 26:337-344
40. 2-adrenergic receptor: extending the ternary complex model. J Biol Chem 268:4625-4636
41. Schwartz M, Imperato-McGinley A, Peterson RE, Cooper E, Morris PL, MacGillivrary M, Hensle T (1981) Male pseudohermaphroditism secondary to an abnormality in Leydig cell differentiation. J Clin Endocrinol Metab 53:123-127
42. Segaloff DL, Ascoli M (1993) The lutropin/choriogonadotropin (LH/CG) receptor-4 years later. Endocr Rev 14:324-347
43. Sheikh SP, Vilardarga J-P, Baranski TJ, Lichtarge O, Iiri T, Meng EC, Nissenson RA, et al (1999) Similar structures and shared switch mechanisms of the β2-adrenoceptor and the parathyroid hormone receptor: Zn(II) bridges between helices III and VI block activation. J Biol Chem 274:17033-17041
44. Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T, Cutler GB Jr (1993) A constitutively Activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365:652-654
45. Stavrou SS, Zhu Y-S, Cai LQ, Katz MD, Herrara C, DeFillo-Ricart M, Imperato-McGinley J (1998) A novel mutation of the human luteinizing hormone receptor in 46XY and 46XX sisters. J Clin Endocrinol Metab 83:2091-2098
46. Toledo SPA, Brunner HG, Kraaij R, Post M, Dahia PLM, Hayashida CY, Kremer H, et al (1996) An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J Clin Endocrinol Metab 81:3850-3854
47. Wu SM, Hallermeier KM, Laue L, Brain C, Berry C, Grant DB, Griffin J, et al (1998) Inactivating of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia. Mol Endocrinol 12:1651-1660
48. Yano K, Hidaka A, Saji M, Polymeropoulos MH, Okuno A, Kohn LD, Curler GB (1994) A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases. J Clin Endocrinol Metab 79:1818-1823
49. Yano K, Kohn LD, Saji M, Kataoka N, Okuno A, Cutler GB Jr (1996) A case of male-limited precocious puberty caused by a point mutation in the second transmembrane domain of the luteinizing hormone choriogonadotropin receptor gene. Biochem Biophys Res Commun 220:1036-1042